Comparison of NT-proBNP levels in hemodialysis versus
peritoneal dialysis patients

J 2013

Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients

LUDKA, Ondřej; Jindřich ŠPINAR; Josef TOMANDL a Tomas KONECNY

Základní údaje

Originální název

Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients

Autoři

LUDKA, Ondřej; Jindřich ŠPINAR; Josef TOMANDL a Tomas KONECNY

Vydání

Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic, Olomouc, Palacký University, 2013, 1213-8118

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.661

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/13:00071001

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.5507/bp.2012.101

UT WoS

000329091500010

Klíčová slova anglicky

Continuous ambulatory peritoneal dialysis; Ejection fraction; Hemodialysis; NT-proBNP

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 13. 4. 2014 11:46, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Background. Plasma N-terminal fragment of pro brain natriuretic peptide (NT-proBNP) concentration is elevated in cardiovascular diseases such as congestive heart failure, where increased levels of NT-proBNP indicate cardiac dysfunction, hypervolemia, and higher risk of hospitalization and death. These associations apply also to patients with severe impairment of kidney function. Little is known about diferences in plasma level of NT-proBNP in patients receiving hemodialysis (HD) versus those receiving continuous ambulatory peritoneal dialysis (CAPD). Aim. To evaluate differences in plasma NT-proBNP concentration between HD and CAPD patients. Methods. Plasma NT-proBNP concentration was prospectively measured in consecutive patients receiving either HD or CAPD at our hospital center. All other standard clinical parameters were recorded. The correlation between plasma NT-proBNP concentration and the type of dialysis was then examined. Results. We studied 99 consecutive patients on HD (age 62 +/- 15 years, 66% male) and 18 consecutive patients on CAPD (age 56 +/- 18 years, 67% male). Both groups had similar baseline characteristics including duration of dialysis, left ventricular function and mass, and cardiothoracic ratio. Significantly more patients on HD had abnormal NTproBNP levels compared to patients on CAPD (97% vs 44%; P<0.0001), and this difference remained highly significant when using various NT-proBNP cut off values. A subgroup analysis revealed that the lower NT-proBNP levels of CAPD patients are most pronounced in patients with preserved left ventricular ejection function. As expected, NT-proBNP levels correlated negatively with left ventricular function and positively with cardiothoracic ratio, and this applied to both HD and CAPD groups. Conclusion. The lower concentration of NT-proBNP in patients on CAPD compared to those on HD suggests that CAPD produces lesser hemodynamic stress, especially in patients with preserved left ventricular systolic function. Even though increased NT-proBNP levels have been shown to predict increased morbidity and mortality, further studies are necessary to assess the long term benefit of CAPD compared to HD.

Citovat

LUDKA, Ondřej; Jindřich ŠPINAR; Josef TOMANDL a Tomas KONECNY. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients. Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic. Olomouc: Palacký University, 2013, roč. 157, č. 4, s. 325-330. ISSN 1213-8118. Dostupné z: https://doi.org/10.5507/bp.2012.101.

@article{1159162,
   author = {Ludka, Ondřej and Špinar, Jindřich and Tomandl, Josef and Konecny, Tomas},
   article_location = {Olomouc},
   article_number = {4},
   doi = {https://doi.org/10.5507/bp.2012.101},
   keywords = {Continuous ambulatory peritoneal dialysis; Ejection fraction; Hemodialysis; NT-proBNP},
   language = {eng},
   issn = {1213-8118},
   journal = {Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic},
   title = {Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients},
   volume = {157},
   year = {2013}
}

TY  - JOUR
ID  - 1159162
AU  - Ludka, Ondřej - Špinar, Jindřich - Tomandl, Josef - Konecny, Tomas
PY  - 2013
TI  - Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients
JF  - Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic
VL  - 157
IS  - 4
SP  - 325-330
EP  - 325-330
PB  - Palacký University
SN  - 12138118
KW  - Continuous ambulatory peritoneal dialysis
KW  - Ejection fraction
KW  - Hemodialysis
KW  - NT-proBNP
N2  - Background. Plasma N-terminal fragment of pro brain natriuretic peptide (NT-proBNP) concentration is elevated in cardiovascular diseases such as congestive heart failure, where increased levels of NT-proBNP indicate cardiac dysfunction, hypervolemia, and higher risk of hospitalization and death. These associations apply also to patients with severe impairment of kidney function. Little is known about diferences in plasma level of NT-proBNP in patients receiving hemodialysis (HD) versus those receiving continuous ambulatory peritoneal dialysis (CAPD). Aim. To evaluate differences in plasma NT-proBNP concentration between HD and CAPD patients. Methods. Plasma NT-proBNP concentration was prospectively measured in consecutive patients receiving either HD or CAPD at our hospital center. All other standard clinical parameters were recorded. The correlation between plasma NT-proBNP concentration and the type of dialysis was then examined. Results. We studied 99 consecutive patients on HD (age 62 +/- 15 years, 66% male) and 18 consecutive patients on CAPD (age 56 +/- 18 years, 67% male). Both groups had similar baseline characteristics including duration of dialysis, left ventricular function and mass, and cardiothoracic ratio. Significantly more patients on HD had abnormal NTproBNP levels compared to patients on CAPD (97% vs 44%; P<0.0001), and this difference remained highly significant when using various NT-proBNP cut off values. A subgroup analysis revealed that the lower NT-proBNP levels of CAPD patients are most pronounced in patients with preserved left ventricular ejection function. As expected, NT-proBNP levels correlated negatively with left ventricular function and positively with cardiothoracic ratio, and this applied to both HD and CAPD groups. Conclusion. The lower concentration of NT-proBNP in patients on CAPD compared to those on HD suggests that CAPD produces lesser hemodynamic stress, especially in patients with preserved left ventricular systolic function. Even though increased NT-proBNP levels have been shown to predict increased morbidity and mortality, further studies are necessary to assess the long term benefit of CAPD compared to HD.
ER  -

LUDKA, Ondřej; Jindřich ŠPINAR; Josef TOMANDL a Tomas KONECNY. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients. \textit{Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic}. Olomouc: Palacký University, 2013, roč.~157, č.~4, s.~325-330. ISSN~1213-8118. Dostupné z: https://doi.org/10.5507/bp.2012.101.

Přehled o publikaci